Demirkaya E - Search Results

1

EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases.

Foster HE, Minden K, Clemente D, Leon L, McDonagh JE, Kamphuis S, Berggren K, van Pelt P, Wouters C, Waite-Jones J, Tattersall R, Wyllie R, Stones SR, Martini A, Constantin T, Schalm S, Fidanci B, Erer B, Demirkaya E, Ozen S, Carmona L. Foster HE, et al. Among authors: demirkaya e. Ann Rheum Dis. 2017 Apr;76(4):639-646. doi: 10.1136/annrheumdis-2016-210112. Epub 2016 Nov 1. Ann Rheum Dis. 2017. PMID: 27802961 Free article.

2

A patient with hyper-IgD syndrome responding to anti-TNF treatment.

Demirkaya E, Caglar MK, Waterham HR, Topaloglu R, Ozen S. Demirkaya E, et al. Clin Rheumatol. 2007 Oct;26(10):1757-9. doi: 10.1007/s10067-006-0501-1. Epub 2006 Dec 15. Clin Rheumatol. 2007. PMID: 17171314

3

A very frequent mutation and remarkable association of R761H with M694V mutations in Turkish familial Mediterranean fever patients.

Demirkaya E, Tunca Y, Gok F, Ozen S, Gul D. Demirkaya E, et al. Clin Rheumatol. 2008 Jun;27(6):729-32. doi: 10.1007/s10067-007-0780-1. Epub 2007 Nov 14. Clin Rheumatol. 2008. PMID: 18000697

4

Neuropsychiatric involvement in juvenile systemic lupus erythematosus.

Demirkaya E, Bilginer Y, Aktay-Ayaz N, Yalnizoğlu D, Karli-Oğuz K, Işikhan V, Türker T, Topaloğlu R, Beşbaş N, Bakkaloğlu A, Ozen S. Demirkaya E, et al. Turk J Pediatr. 2008 Mar-Apr;50(2):126-31. Turk J Pediatr. 2008. PMID: 18664075

5

Musculoskeletal sonography in juvenile systemic lupus erythematosus.

Demirkaya E, Ozçakar L, Türker T, Haghari S, Ayaz NA, Bakkaloglu A, Ozen S. Demirkaya E, et al. Arthritis Rheum. 2009 Jan 15;61(1):58-60. doi: 10.1002/art.24090. Arthritis Rheum. 2009. PMID: 19116978 Free article.

6

Current educational status of paediatric rheumatology in Europe: the results of PReS survey.

Demirkaya E, Ozen S, Türker T, Kuis W, Saurenmann RK. Demirkaya E, et al. Clin Exp Rheumatol. 2009 Jul-Aug;27(4):685-90. Clin Exp Rheumatol. 2009. PMID: 19772807

7

Purpura fulminans as the presenting manifestation in a patient with juvenile SLE.

Demirkaya E, Cakmakli HF, Güçer S, Aktay-Ayaz N, Gürgey A, Ozen S. Demirkaya E, et al. Turk J Pediatr. 2009 Jul-Aug;51(4):378-80. Turk J Pediatr. 2009. PMID: 19950848

8

Preventing tuberculosis in children receiving anti-TNF treatment.

Ayaz NA, Demirkaya E, Bilginer Y, Ozçelik U, Cobanoğlu N, Kiper N, Besbas N, Bakkaloğlu A, Ozen S. Ayaz NA, et al. Among authors: demirkaya e. Clin Rheumatol. 2010 Apr;29(4):389-92. doi: 10.1007/s10067-009-1334-5. Clin Rheumatol. 2010. PMID: 20084445

9

Genotoxicity of anti-tumor necrosis factor therapy in patients with juvenile idiopathic arthritis.

Demirkaya E, Cok I, Durmaz E, Ulutas OK, Ayaz NA, Besbas N, Ozen S. Demirkaya E, et al. Arthritis Care Res (Hoboken). 2010 Jan 15;62(1):73-7. doi: 10.1002/acr.20016. Arthritis Care Res (Hoboken). 2010. PMID: 20191493 Free article.

10

Criteria to define response to therapy in paediatric rheumatic diseases.

Ruperto N, Pistorio A, Ravelli A, Hasija R, Guseinova D, Filocamo G, Demirkaya E, Malattia C, Martini A; Paediatric Rheumatology International Trials Organisation (PRINTO). Ruperto N, et al. Among authors: demirkaya e. Eur J Clin Pharmacol. 2011 May;67 Suppl 1:125-31. doi: 10.1007/s00228-010-0937-8. Epub 2010 Nov 20. Eur J Clin Pharmacol. 2011. PMID: 21103985 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

137 results

Search Page